272 related articles for article (PubMed ID: 17949798)
21. Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer.
Kietpeerakool C; Tiyayon J; Suprasert P; Kanjanavanit R; Srisomboon J
J Med Assoc Thai; 2006 Nov; 89(11):1805-10. PubMed ID: 17205858
[TBL] [Abstract][Full Text] [Related]
22. [Neoadjuvant chemotherapy in the treatment of ovarian cancer].
Lehoczky O
Orv Hetil; 2005 Sep; 146(38):1951-5. PubMed ID: 16238247
[TBL] [Abstract][Full Text] [Related]
23. [Rectal perforation in a patient treated with combination chemotherapy for lung cancer].
Samejima J; Adachi H; Kawamoto M; Saeki H; Kato N; Fujisawa J; Matsukawa H; Rino Y; Masuda M
Gan To Kagaku Ryoho; 2009 Feb; 36(2):301-4. PubMed ID: 19223751
[TBL] [Abstract][Full Text] [Related]
24. [A case of ovarian cancer stage IV and advanced rectal cancer responding to paclitaxel/carboplatin].
Kawaguchi R; Furukawa N; Morimoto Y; Ohi M; Osawa T; Koike H; Miyake T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):619-22. PubMed ID: 15114712
[TBL] [Abstract][Full Text] [Related]
25. Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
Le T; Williams K; Senterman M; Hopkins L; Faught W; Fung-Kee-Fung M
Gynecol Oncol; 2007 Jul; 106(1):160-3. PubMed ID: 17490737
[TBL] [Abstract][Full Text] [Related]
26. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin.
Takekuma M; Hirashima Y; Takahashi N; Yamamichi G; Furukawa N; Yamada Y; Takakuwa R; Ito I
Anticancer Drugs; 2006 Jul; 17(6):715-8. PubMed ID: 16917218
[TBL] [Abstract][Full Text] [Related]
27. [Advanced ovarian cancer with Sister Mary Joseph's nodule--a case report].
Ohta S; Yamakawa Y; Hasegawa T; Tateno M; Matsui K
Gan To Kagaku Ryoho; 2007 Jan; 34(1):117-9. PubMed ID: 17220685
[TBL] [Abstract][Full Text] [Related]
28. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.
Fader AN; von Gruenigen V; Gibbons H; Abushahin F; Starks D; Markman M; Belinson J; Rose P
Gynecol Oncol; 2008 Apr; 109(1):33-8. PubMed ID: 18261784
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic factors of ovarian cancer].
Ochiai K
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
[TBL] [Abstract][Full Text] [Related]
30. Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates.
Landrum LM; Gold MA; Moore KN; Myers TK; McMeekin DS; Walker JL
Gynecol Oncol; 2008 Feb; 108(2):342-7. PubMed ID: 17988721
[TBL] [Abstract][Full Text] [Related]
31. Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer.
Markman M
Gynecol Oncol; 2007 Jul; 106(1):273-4; author reply 274-5. PubMed ID: 17467780
[No Abstract] [Full Text] [Related]
32. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC
Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166
[No Abstract] [Full Text] [Related]
33. LTE-commenting on "Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer" (90: 163-9).
Eisenkop SM
Gynecol Oncol; 2004 Mar; 92(3):1017-8; author reply 1018-9. PubMed ID: 14984983
[No Abstract] [Full Text] [Related]
34. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
[TBL] [Abstract][Full Text] [Related]
35. Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.
Onda T; Matsumoto K; Shibata T; Sato A; Fukuda H; Konishi I; Kamura T; Yoshikawa H;
Jpn J Clin Oncol; 2008 Jan; 38(1):74-7. PubMed ID: 18258715
[TBL] [Abstract][Full Text] [Related]
36. Weekly low-dose paclitaxel and carboplatin therapy in gynecological cancer patients with venous thrombosis.
Tabata T; Tanida K; Umekawa T; Shiozaki T; Kondo E; Nagao K; Okugawa T; Sagawa N
Anticancer Res; 2008; 28(6B):3971-5. PubMed ID: 19192658
[TBL] [Abstract][Full Text] [Related]
37. Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival.
Alberts DS; Marth C; Alvarez RD; Johnson G; Bidzinski M; Kardatzke DR; Bradford WZ; Loutit J; Kirn DH; Clouser MC; Markman M;
Gynecol Oncol; 2008 May; 109(2):174-81. PubMed ID: 18314182
[TBL] [Abstract][Full Text] [Related]
38. The Immune adjuvant properties of front-line carboplatin-paclitaxel: a randomized phase 2 study of alternative schedules of intravenous oregovomab chemoimmunotherapy in advanced ovarian cancer.
Braly P; Nicodemus CF; Chu C; Collins Y; Edwards R; Gordon A; McGuire W; Schoonmaker C; Whiteside T; Smith LM; Method M
J Immunother; 2009 Jan; 32(1):54-65. PubMed ID: 19307994
[TBL] [Abstract][Full Text] [Related]
39. [Ovarian cancer treatment from the standpoint of the gynecologic oncologist].
Sugiyama T; Yoshizaki A; Hatayama S
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1011-6. PubMed ID: 17637537
[TBL] [Abstract][Full Text] [Related]
40. [Ovarian cancer].
Onda T
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1735-9. PubMed ID: 18030006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
